Literature DB >> 28178044

Interpregnancy Interval and Adverse Pregnancy Outcomes: An Analysis of Successive Pregnancies.

Gillian E Hanley1, Jennifer A Hutcheon, Brooke A Kinniburgh, Lily Lee.   

Abstract

OBJECTIVE: To examine the association between interpregnancy interval and maternal-neonate health when matching women to their successive pregnancies to control for differences in maternal risk factors and compare these results with traditional unmatched designs.
METHODS: We conducted a retrospective cohort study of 38,178 women with three or more deliveries (two or greater interpregnancy intervals) between 2000 and 2015 in British Columbia, Canada. We examined interpregnancy interval (0-5, 6-11, 12-17, 18-23 [reference], 24-59, and 60 months or greater) in relation to neonatal outcomes (preterm birth [less than 37 weeks of gestation], small-for-gestational-age birth [less than the 10th centile], use of neonatal intensive care, low birth weight [less than 2,500 g]) and maternal outcomes (gestational diabetes, beginning the subsequent pregnancy obese [body mass index 30 or greater], and preeclampsia-eclampsia). We used conditional logistic regression to compare interpregnancy intervals within the same mother and unconditional (unmatched) logistic regression to enable comparison with prior research.
RESULTS: Analyses using the traditional unmatched design showed significantly increased risks associated with short interpregnancy intervals (eg, there were 232 preterm births [12.8%] in 0-5 months compared with 501 [8.2%] in the 18-23 months reference group; adjusted odds ratio [OR] for preterm birth 1.53, 95% confidence interval [CI] 1.35-1.73). However, these risks were eliminated in within-woman matched analyses (adjusted OR for preterm birth 0.85, 95% CI 0.71-1.02). Matched results indicated that short interpregnancy intervals were significantly associated with increased risk of gestational diabetes (adjusted OR 1.35, 95% CI 1.02-1.80 for 0-5 months) and beginning the subsequent pregnancy obese (adjusted OR 1.61, 95% CI 1.05-2.45 for 0-5 months and adjusted OR 1.43, 95% CI 1.10-1.87 for 6-11 months).
CONCLUSION: Previously reported associations between short interpregnancy intervals and adverse neonatal outcomes may not be causal. However, short interpregnancy interval is associated with increased risk of gestational diabetes and beginning a subsequent pregnancy obese.

Entities:  

Mesh:

Year:  2017        PMID: 28178044     DOI: 10.1097/AOG.0000000000001891

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  53 in total

1.  Interdelivery Interval and Diabetes Mellitus in a Subsequent Pregnancy.

Authors:  Annie M Dude; Ashley Battarbee; Lynn M Yee
Journal:  Am J Perinatol       Date:  2018-11-30       Impact factor: 1.862

2.  The duration of the interpregnancy interval in multiparous women and maternal weight gain between pregnancies: findings from a UK population-based cohort.

Authors:  Nida Ziauddeen; Paul J Roderick; Nicholas S Macklon; Nisreen A Alwan
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

3.  Regan et al. Reply to "Sibling Comparison Design in Birth-Spacing Studies".

Authors:  Annette K Regan; Stephen J Ball; Joshua L Warren; Eva Malacova; Cicely Marston; Natasha Nassar; Helen Leonard; Nicholas de Klerk; Gavin Pereira
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

4.  Medicaid and receipt of interval postpartum long-acting reversible contraception.

Authors:  Barbara Wilkinson; Mustafa Ascha; Emily Verbus; Mary Montague; Jane Morris; Brian Mercer; Kavita Shah Arora
Journal:  Contraception       Date:  2018-09-05       Impact factor: 3.375

5.  Invited Commentary: The Causal Association Between Obesity and Stillbirth-Strengths and Limitations of the Consecutive-Pregnancies Approach.

Authors:  Jonathan M Snowden; Stephanie A Leonard
Journal:  Am J Epidemiol       Date:  2019-07-01       Impact factor: 4.897

6.  Role of Bridge Contraception in Postpartum Long-Acting Reversible Contraception and Sterilization Fulfillment Rates.

Authors:  Mary Montague; Mustafa Ascha; Barbara Wilkinson; Emily Verbus; Jane Morris; Brian M Mercer; Kavita Shah Arora
Journal:  Obstet Gynecol       Date:  2018-09       Impact factor: 7.661

7.  Interpregnancy Interval and Risk of Adverse Pregnancy Outcomes: A Register-Based Study of 328,577 Pregnancies in Denmark 1994-2010.

Authors:  Emilie Rune Hegelund; Stine Kjaer Urhoj; Anne-Marie Nybo Andersen; Laust Hvas Mortensen
Journal:  Matern Child Health J       Date:  2018-07

Review 8.  Comparative risks and predictors of preeclamptic pregnancy in the Eastern, Western and developing world.

Authors:  Ning Zhang; Jing Tan; HaiFeng Yang; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2020-09-25       Impact factor: 5.858

9.  Coverage of immediate postpartum long-acting reversible contraception has improved birth intervals for at-risk populations.

Authors:  Abigail Liberty; Kimberly Yee; Blair G Darney; Ana Lopez-Defede; Maria I Rodriguez
Journal:  Am J Obstet Gynecol       Date:  2019-12-14       Impact factor: 8.661

Review 10.  Costs of reproduction and ageing in the human female.

Authors:  Grazyna Jasienska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-09-21       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.